SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regenerons third-quarter earnings beat, driven by growth in Dupixent and Eylea HD, fueled a sharp rally and a new 52-week high. Traders are largely upbeat about the breadth of growth, while noting that legacy Eylea sales and biosimilar competition remain risks.

OFFICIAL TRUMP (TRUMP) is a cryptocurrency and operates on the Solana platform. OFFICIAL TRUMP has a current supply of 999,998,811.032761 with 281,866,747.320393 in circulation. The last known price of OFFICIAL TRUMP is 1.57555883 USD and is down -1.93 over the last 24 hours. It is currently trading on 744 active market(s) with $126,884,732.61 traded over the last 24 hours. More information can be found at https://gettrumpmemes.com/.

Trump For President

Discussion centers on the Trump-themed meme coins steep decline and traders allegations that it was a cash grab, with holders debating whether to keep accumulating or expect further losses. A smaller bullish contingent points to possible rebounds or short squeezes.

Teradyne, Inc. engages in the development and sale of automatic test systems. It operates through the following business segments: Semiconductor Test, Robotics, and All Other. The Semiconductor Test segment designs, manufactures, and markets semiconductor test products and services. The Robotics segment includes operations related to the design, manufacturing, and marketing of collaborative robotic arms, autonomous mobile robots, and advanced robotic control software. The company was founded by Alexander V. d'Arbeloff and Nicholas DeWolf in 1960 and is headquartered in North Reading, MA.

Teradyne, Inc.

Teradyne is selling off despite a strong Q3 beat, with traders focused on guidance viewed as underwhelming and concerns about product-mix margin pressure. Bulls point to AI-driven chip-testing demand, while bears question the valuation and near-term growth outlook.

Dogecoin (DOGE) is a cryptocurrency . Users are able to generate DOGE through the process of mining. Dogecoin has a current supply of 156,559,996,383.70523. The last known price of Dogecoin is 0.07552377 USD and is down -0.48 over the last 24 hours. It is currently trading on 1543 active market(s) with $337,365,256.17 traded over the last 24 hours. More information can be found at http://dogecoin.com/.

Dogecoin

Dogecoins persistent weakness and choppy trading dominate the discussion, with traders pointing to bearish technical setups and its moves alongside a broadly weak crypto market. Some holders are buying the dip and hoping for a rebound, while others are frustrated by the stalled price action and skeptical about the tokens prospects.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

FDA approval of Inovios competing RRP treatment has raised concerns that it could threaten Precigens PAPZIMEOS business and triggered a sharp after-hours selloff. Traders are divided: some see Inovios treatment as a serious competitor, while others point to Precigens first-mover advantage, established sales and full approval, alongside questions about Inovios accelerated-approval status and ability to commercialize.

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. The Commercial Product Sales segment includes NARCAN products and other commercial products that were sold as part of the travel health business. The MCM Product Sales segment focuses on the Anthrax - MCM products, Smallpox - MCM products and other products. The Services segment consists of the company’s Bioservices offerings. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Emergent Biosolutions Inc

Emergents CFO retirement and the appointment of its treasurer as interim successor have fueled concern about leadership and financial risk, with some traders speculating about deeper problems while others view the handoff as routine. Attention is also focused on the upcoming quarterly results for signs of how the companys turnaround is progressing.

Lennar Corp. engages in the provision of real estate related financial and investment management services. It operates through the following segments: Homebuilding, Financial Services, Multifamily, and Lennar Other. The Homebuilding segment refers to the construction and sale of single-family attached and detached homes and the purchase, development, and sale of residential land directly and through entities. The Financial Services segment focuses on mortgage financing, title, and closing services for buyers. The Multifamily segment is involved in the development, construction, and property management of multifamily rental properties. The Lennar Other segment includes funds, asset management platform, and strategic investments in technology companies. The company was founded in 1954 and is headquartered in Miami, FL.

Lennar Corp. - Ordinary Shares - Class A

Lennar Corp.

Traders are focused on Berkshire Hathaways growing Lennar stake and a Hunterbrook short report alleging Millrose, Lennars related spinoff, bought completed homes from the builder. Bulls see Berkshires buying as a value signal, while bears question the transactions and point to high mortgage rates and weak housing demand as ongoing risks.

Corvus Pharmaceuticals, Inc. engages in the development of product candidates for the treatment of cancer and immune-mediated and inflammatory diseases. Its product candidates include soquelitinib, an ITK inhibitor, ciforadenant, an adenosine A2A receptor antagonist, and mupadolimab, a B cell-activating anti-CD73 antibody. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Soquelitinibs atopic-dermatitis data and a company presentation are driving discussion, with bullish traders calling the results encouraging while others criticize the event for not providing enough new information. Shares sold off despite the positive readout, amid debate over safety, limited follow-up, and the early-stage evidence.

Zoom Communications, Inc. engages in the provision of a communications and collaboration platform. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa. The company was founded by Eric S. Yuan in 2011 and is headquartered in San Jose, CA.

Zoom Communications Inc. - Ordinary Shares - Class A

Anthropics confidential IPO filing has renewed attention on Zoom as a public-market proxy for its private-company stake, with traders debating how much that holding could be worth and whether the potential upside is already priced in. Zooms earnings and AI-product momentum also feature in the discussion, but some investors remain skeptical that either will overcome its modest core-business growth.

VS Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

A sharp volatility spike has driven UVIX higher, with traders linking the move to market weakness and concerns around oil, interest rates, and geopolitical risk. Some are adding volatility hedges and celebrating the return of market fear, while others warn the leveraged ETF can quickly lose value through decay and expect the spike to fade.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


soc88casinoxcom

Soc88